Guardant Health’s 117% Boom! But Are AI Stocks A BETTER Bet NOW?
Did you know that Guardant Health shares surged an astonishing 117.89% over the past year, even amidst a slight one-month dip? Carillon Eagle Small Cap Growth Fund recently spotlighted this precision oncology company as a key contributor to its portfolio, praising its pioneering liquid biopsy technology for cancer detection. The company boasts robust financial performance, strategic progress with FDA submissions, and improved margins, positioning it for early cash flow breakeven. However, despite these impressive gains and promising outlook, some investment experts suggest that certain AI stocks might offer even greater upside potential with less risk. Don't miss out on crucial market analysis; subscribe to our channel for unbiased investment insights today!
Tags/Hashtags: #investing
Leave a Reply